Hla-Sensitized Kidney Transplant Recipients Receiving Rituximab And Intravenous Immunoglobulin As Part Of Induction Therapy: A Single Center Eight-Year Experience
AuthID
P-00N-312
P-00N-312
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service